chr10-58513048-C-T
Variant names:
Variant summary
Our verdict is Benign. The variant received -18 ACMG points: 0P and 18B. BP4_ModerateBP6_Very_StrongBS1BS2
The NM_001080512.3(BICC1):c.-96C>T variant causes a 5 prime UTR change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.0152 in 980,452 control chromosomes in the GnomAD database, including 167 homozygotes. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Likely benign (★★).
Frequency
Genomes: 𝑓 0.014 ( 27 hom., cov: 33)
Exomes 𝑓: 0.016 ( 140 hom. )
Consequence
BICC1
NM_001080512.3 5_prime_UTR
NM_001080512.3 5_prime_UTR
Scores
1
1
Clinical Significance
Conservation
PhyloP100: 0.629
Genes affected
BICC1 (HGNC:19351): (BicC family RNA binding protein 1) This gene encodes an RNA-binding protein that is active in regulating gene expression by modulating protein translation during embryonic development. Mouse studies identified the corresponding protein to be under strict control during cell differentiation and to be a maternally provided gene product. [provided by RefSeq, Apr 2009]
Genome browser will be placed here
ACMG classification
Classification was made for transcript
Our verdict: Benign. The variant received -18 ACMG points.
BP4
Computational evidence support a benign effect (BayesDel_noAF=-0.36).
BP6
Variant 10-58513048-C-T is Benign according to our data. Variant chr10-58513048-C-T is described in ClinVar as [Likely_benign]. Clinvar id is 1219757.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars.
BS1
Variant frequency is greater than expected in population sas. GnomAd4 allele frequency = 0.0136 (2046/150468) while in subpopulation SAS AF = 0.0355 (171/4816). AF 95% confidence interval is 0.0312. There are 27 homozygotes in GnomAd4. There are 1107 alleles in the male GnomAd4 subpopulation. Median coverage is 33. This position FAILED quality control check.
BS2
High AC in GnomAd4 at 2046 AD gene.
Transcripts
RefSeq
Ensembl
Frequencies
GnomAD3 genomes AF: 0.0136 AC: 2047AN: 150362Hom.: 27 Cov.: 33 show subpopulations
GnomAD3 genomes
AF:
AC:
2047
AN:
150362
Hom.:
Cov.:
33
Gnomad AFR
AF:
Gnomad AMI
AF:
Gnomad AMR
AF:
Gnomad ASJ
AF:
Gnomad EAS
AF:
Gnomad SAS
AF:
Gnomad FIN
AF:
Gnomad MID
AF:
Gnomad NFE
AF:
Gnomad OTH
AF:
GnomAD4 exome AF: 0.0155 AC: 12868AN: 829984Hom.: 140 AF XY: 0.0159 AC XY: 6365AN XY: 400118 show subpopulations
GnomAD4 exome
AF:
AC:
12868
AN:
829984
Hom.:
AF XY:
AC XY:
6365
AN XY:
400118
Gnomad4 AFR exome
AF:
AC:
38
AN:
16788
Gnomad4 AMR exome
AF:
AC:
74
AN:
6712
Gnomad4 ASJ exome
AF:
AC:
179
AN:
11038
Gnomad4 EAS exome
AF:
AC:
3
AN:
21474
Gnomad4 SAS exome
AF:
AC:
727
AN:
17444
Gnomad4 FIN exome
AF:
AC:
1020
AN:
22204
Gnomad4 NFE exome
AF:
AC:
10269
AN:
698234
Gnomad4 Remaining exome
AF:
AC:
514
AN:
33772
Heterozygous variant carriers
0
582
1164
1746
2328
2910
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance
Exome Het
Exome Hom
Variant carriers
0
428
856
1284
1712
2140
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
GnomAD4 genome AF: 0.0136 AC: 2046AN: 150468Hom.: 27 Cov.: 33 AF XY: 0.0151 AC XY: 1107AN XY: 73496 show subpopulations
GnomAD4 genome
AF:
AC:
2046
AN:
150468
Hom.:
Cov.:
33
AF XY:
AC XY:
1107
AN XY:
73496
Gnomad4 AFR
AF:
AC:
0.00227394
AN:
0.00227394
Gnomad4 AMR
AF:
AC:
0.00754367
AN:
0.00754367
Gnomad4 ASJ
AF:
AC:
0.022029
AN:
0.022029
Gnomad4 EAS
AF:
AC:
0.000195389
AN:
0.000195389
Gnomad4 SAS
AF:
AC:
0.0355066
AN:
0.0355066
Gnomad4 FIN
AF:
AC:
0.0427039
AN:
0.0427039
Gnomad4 NFE
AF:
AC:
0.0166173
AN:
0.0166173
Gnomad4 OTH
AF:
AC:
0.0143541
AN:
0.0143541
Heterozygous variant carriers
0
111
222
334
445
556
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance
Genome Het
Genome Hom
Variant carriers
0
26
52
78
104
130
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
Hom.:
Bravo
AF:
ClinVar
Significance: Likely benign
Submissions summary: Benign:2
Revision: criteria provided, multiple submitters, no conflicts
LINK: link
Submissions by phenotype
not provided Benign:2
-
Breakthrough Genomics, Breakthrough Genomics
Significance:Likely benign
Review Status:criteria provided, single submitter
Collection Method:not provided
- -
Jan 13, 2020
GeneDx
Significance:Likely benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing
- -
Computational scores
Source:
Name
Calibrated prediction
Score
Prediction
BayesDel_noAF
Benign
DANN
Uncertain
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at